in 36 patients with primary hepatocellular carcinoma , the cona-nonreactive form of afp comprised less than 20 % of the total ( range 1.6 % -19.2 % ; median 8.7 % ) , whereas in 13 patients with metastatic liver disease the cona-nonreactive form comprised more than 20 % of the total ( range 26.6 % -91.7 % ; median 57.6 % ) .
C0279000
primary hepatocellular carcinoma
C0023884
liver